Ken Griffin Pfizer Inc Put Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$27.7 - $31.39 $132 Million - $150 Million	-4,764,000 Reduced 16.1%	24,826,600 $718 Million
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $25.8 Million - $30.3 Million	1,022,900 Added 3.58%	29,590,600 $828 Million
Q1 2024 May 15, 2024	BUY	$25.89 - $29.73 $191 Million - $220 Million	7,386,400 Added 34.87%	28,567,700 $793 Million
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $60 Million - $77.9 Million	2,295,400 Added 12.15%	21,181,300 $610 Million
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $47.5 Million - $55.5 Million	1,480,400 Added 8.51%	18,885,900 $626 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $335 Million - $388 Million	9,277,000 Added 114.13%	17,405,500 $638 Million
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $204 Million - $265 Million	-5,171,300 Reduced 38.88%	8,128,500 $332 Million
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $239 Million - $312 Million	5,719,400 Added 75.45%	13,299,800 $682 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $8.9 Million - $10.9 Million	203,300 Added 2.76%	7,580,400 $332 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.